In The Future of Species, Adrian Woolfson updates Charles Darwin’s classic narrative with a startling new vision – revealing that in the future the genomes of species, including our own, may be authored rather than evolved. Woolfson, a scientist at the forefront of this new technology, guides us on an exhilarating journey as he boldly navigates some of the most important issues of the present day. We’ll learn that the ability to write genomes rapidly and inexpensively will spark a biological technological revolution, changing the nature of disease, addressing environmental concerns and open up a new bioeconomy. The Future of Species not only highlights the immense possibilities of genome synthesis but also addresses the ethical and societal implications that come with such power. Woolfson navigates the complex terrain of bioethics, discussing the need for responsible research practices, transparency and public engagement to ensure the technology is used for the greater good. Sparkling with critical ideas and discoveries, The Future of Species tackles who we are as a species and what we are likely to become.
On the Future of Species
By Adrian Woolfson
A ground-breaking exploration of the emerging field of genome writing and its profound implications for healthcare, the environment and the global economyMaterial available
Rights Sold
Croatian, Dutch; FlemishBook Details
Imprint: Bloomsbury Publishing (UK) | Pub date: February 2026 | Format: 234 x 153mm | Extent: 336 pages | Word Count: 69,000 wordsAbout the Author
Adrian Woolfson is the co-founder of Replay, a genomic medicine, genome writing, and cell therapy biotechnology company based in San Diego, California. He was born in London, studied medicine at Balliol College, Oxford, and was formerly the Charles and Katherine Darwin Fellow at Darwin College, Cambridge. Woolfson is the author of the critically acclaimed Life Without Genes: The History and Future of Genomes (2000) and An Intelligent Person’s Guide to Genetics (2006). He has authored over 150 scientific papers, book chapters, reviews, and patents, and is a regular contributor to the Wall Street Journal, Washington Post and Science magazine.